Parkman Healthcare Partners’s Centene CNC Stock Holding History

Parkman Healthcare Partners’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-55,794	Closed	-$4.38M	–	94
2024 Q1	$4.38M	Buy	+55,794	New	+$4.31M	0.54%	61

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Parkman Healthcare Partners's CNC Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of Centene (CNC) in Q2 2024, closing a stake of 55,794 shares — an estimated $4.38M sold.

Parkman Healthcare Partners first reported a position in CNC in Q1 2024 and held it in 1 quarter. The position peaked at $4.38M in Q1 2024. 896 funds tracked by Wall St. Rank hold CNC as of Q2 2024.

Parkman Healthcare Partners reported no remaining Centene position as of Q2 2024 after selling out during the quarter.
Parkman Healthcare Partners sold 55,794 Centene shares in Q2 2024, an estimated $4.38M.
Parkman Healthcare Partners first reported a position in Centene in Q1 2024 and held it in 1 quarter.
Parkman Healthcare Partners's Centene position peaked at $4.38M in Q1 2024.
896 funds tracked by Wall St. Rank held Centene as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.